WebApr 14, 2024 · Among the extracellular vesicles, apoptotic bodies (ABs) are only formed during the apoptosis and perform a relevant role in the pathogenesis of different … WebThe beneficial effects of cisplatin, which is the most widely used agent for CCRT in CC patients, whether alone or in combination with other drugs, were not independently …
Targeted therapy for cisplatin‐resistant lung cancer via …
Cisplatin is approved to be used alone or with other drugs to treat: 1. Bladder cancer. It is used alone in patients with advanced cancer … See more Find Clinical Trials for Cisplatin- Check for trials from NCI's list of cancer clinical trials now accepting patients. See more Definition from the NCI Drug Dictionary- Detailed scientific definition and other names for this drug. MedlinePlus Information on Cisplatin- A lay language summary of important information about this drug that may … See more WebThey are known as central venous catheters (CVCs), central venous access devices (CVADs), or central lines. They are used to put medicines, blood products, nutrients, or fluids right into your blood. They can also be used to take out blood for testing. Many different kinds of CVCs are available. the process of food being digested
Cisplatin 12. Modes of Action of Cisplatin - Chemistry LibreTexts
WebApr 4, 2024 · Carboplatin belongs to a class of medications known as platinum-containing compounds. It works by stopping or slowing the growth of cancer cells. Carboplatin is used in adults in combination with other cancer treatments to treat ovarian cancer. WebSep 18, 2024 · Cisplatin is a medication used to manage and treat solid tumors and hematologic malignancies. It is in the alkylating agent class of cytotoxic medications. This activity reviews the indications, action, and contraindications for cisplatinum as a valuable agent in treating malignancy. WebMale Sprague Dawley rats were used in the experiments. Rats were randomly assigned to one of eight groups: control group; group treated with i.p. injection in a single dose of 7 mg/kg/day cisplatin; groups treated with 50, 100 and 200 mg/kg/day OLE (i.p.); and groups treated with OLE for 3 days starting at 24 h following cisplatin injection. signal light bar